Linscomb & Williams, Inc. Bristol Myers Squibb CO Transaction History

Linscomb & Williams, Inc.

$1.93 Billion
Q2 2024

A detailed history of Linscomb & Williams, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Linscomb & Williams, Inc. holds 4,987 shares of BMY stock, worth $265,258. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,987

Previous 5,629 11.41%

Holding current value

$265,258

Previous $305,000 32.13%

% of portfolio

0.01%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $25,840 - $34,019	-642 Reduced 11.41%	4,987 $207,000
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $20,247 - $22,956	-422 Reduced 6.97%	5,629 $305,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $50,661 - $60,453	-1,045 Reduced 14.73%	6,051 $310,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $9,609 - $10,745	-166 Reduced 2.29%	7,096 $411,000
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $132,198 - $146,785	-2,075 Reduced 22.22%	7,262 $464,000
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $149,753 - $169,853	-2,279 Reduced 19.62%	9,337 $647,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $223,724 - $264,921	3,267 Added 39.13%	11,616 $835,000
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $48 - $28,661	373 Added 4.68%	8,349 $594,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $202,101 - $222,584	-2,783 Reduced 25.87%	7,976 $614,000
Q1 2022 May 17, 2022	BUY	$61.48 - $73.72 $110,602 - $132,622	1,799 Added 20.08%	10,759 $786,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $16,625 - $19,381	310 Added 3.58%	8,960 $559,000
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $17,514 - $20,515	296 Added 3.54%	8,650 $512,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $49,608 - $55,794	836 Added 11.12%	8,354 $527,000
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $6,871 - $7,786	-119 Reduced 1.56%	7,518 $466,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $15,563 - $17,246	271 Added 3.68%	7,637 $460,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $14,033 - $16,407	256 Added 3.6%	7,366 $433,000
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $56,236 - $81,725	-1,212 Reduced 14.56%	7,110 $396,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $140,839 - $183,711	2,862 Added 52.42%	8,322 $534,000
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $44,609 - $52,890	-1,043 Reduced 16.04%	5,460 $277,000
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $80,048 - $88,515	1,794 Added 38.1%	6,503 $295,000
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $7,219 - $8,608	-160 Reduced 3.29%	4,709 $225,000
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $43,932 - $56,970	-901 Reduced 15.62%	4,869 $253,000
Q3 2018 Nov 08, 2018	BUY	$55.19 - $62.25 $50,664 - $57,145	918 Added 18.92%	5,770 $358,000
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $4,850 - $6,046	96 Added 2.02%	4,852 $269,000
Q4 2017 Feb 02, 2018	BUY	$59.94 - $65.35 $76,783 - $83,713	1,281 Added 36.86%	4,756 $291,000
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $191,924 - $221,496	3,475	3,475 $221,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.

Account

Linscomb & Williams, Inc. Bristol Myers Squibb CO Transaction History